RxDoctor Payments Data

Melyssa Hancock, MD

Otolaryngology/Facial Plastic Surgery · Boca Raton, FLNPI 1770927642

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,858 of the $4,756 with a category attached, or 81.1%. 22 manufacturers reported payments, led by Aerin Medical Inc. at 29.5% of the total. Reporting peaked in 2019 at $1,450 and has fallen 79.3% since, to $300 in 2025.

$4,756in general payments, 2019–2025

Across 116 payments — averaging $41.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$1K
  • Optinose US, Inc.$685
  • Acclarent, Inc$346
  • Regeneron Healthcare Solutions, Inc.$321
  • Sanofi$301
  • AbbVie$275
  • plus $1K from 16 others
$4,350in research payments, 2019–2025

Across 1 payment — averaging $4350.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Livanova USA, Inc.$4K

What the payments were for

  • Travel & lodging$84518%
  • Food & beverage$3,85881%
  • Entertainment$521%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,756 in reported general payments places this provider in the 80th percentile of 48 otolaryngology/facial plastic surgery providers in Florida.

See all otolaryngology/facial plastic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$107,001
Medicare patients
136
Services billed
1,040

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide106$2,395
Budesonide13$2,073
Montelukast Sodium23$492
Azelastine Hcl13$390
Mupirocin39$237
Fluticasone Propionate21$182
Doxycycline Hyclate11$152
Prednisone20$111
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$106
Levofloxacin19$64

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Boca Raton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →